Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 112 (3) , 677-700
Abstract
No abstract availableKeywords
This publication has 173 references indexed in Scilit:
- Neurodegenerative mutants in Drosophila: a means to identify genes and mechanisms involved in human diseases?Invertebrate Neuroscience, 2005
- Hox Genes and Their Candidate Downstream Targets in the Developing Central Nervous SystemCellular and Molecular Neurobiology, 2005
- Fruit flies for anti-pain drug discoveryLife Sciences, 2005
- GABAergic modulation of motor‐driven behaviors in juvenileDrosophilaand evidence for a nonbehavioral role for GABA transportJournal of Neurobiology, 2004
- Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylaseJournal of Neurobiology, 2003
- Cocaine addiction: Clues from Drosophila on drugsCurrent Biology, 1999
- Activating properties of cocaine and cocaethylene in a behavioral preparation ofDrosophila melanogasterSynapse, 1998
- Glutamate receptors of Drosophila melanogasterFEBS Letters, 1993
- Cell degeneration in the developing optic lobes of the sine oculis and small-optic-lobes mutants of Drosophila melanogasterDevelopmental Biology, 1984
- Acetylcholinesterase mutants in drosophila and their effects on the structure and function of the cental nervous systemJournal of Comparative Neurology, 1980